Financial Ratios

DR LALCHANDANI LABS LTD.

NSE : NABSE : 541299ISIN CODE : INE871Z01013Industry : Hospital & Healthcare ServicesHouse : Private
BSE15.71-0.75 (-4.56 %)
PREV CLOSE ( ) 16.46
OPEN PRICE ( ) 15.71
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8000
TODAY'S LOW / HIGH ( )15.71 15.71
52 WK LOW / HIGH ( ) 15.6835
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-3.612.152.331.091.23
   CEPS(Rs)-2.083.513.522.072.04
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)20.5623.9021.4818.8817.53
   Tax Rate(%)0.0027.4826.5828.2325.79
Margin Ratios
   Core EBITDA Margin(%)1.7721.9122.9820.7922.78
   EBIT Margin(%)-11.2816.7117.7113.8616.26
   Pre Tax Margin(%)-31.0111.4114.0810.8313.67
   PAT Margin (%)-31.018.2710.347.7710.14
   Cash Profit Margin (%)-17.8513.4915.6114.7016.77
Performance Ratios
   ROA(%)-8.725.607.464.306.53
   ROE(%)-16.239.4911.566.019.85
   ROCE(%)-3.6913.0714.889.1712.57
   Asset Turnover(x)0.280.680.720.550.64
   Sales/Fixed Asset(x)0.641.571.781.501.77
   Working Capital/Sales(x)0.881.901.721.071.19
Efficiency Ratios
   Fixed Capital/Sales(x)1.570.640.560.660.57
   Receivable days332.44132.62136.38154.12102.96
   Inventory Days111.4636.1321.9126.5823.01
   Payable days416.11146.80105.53287.38411.81
Valuation Parameters
   PER(x)0.0015.325.967.4115.84
   PCE(x)-13.689.403.953.929.58
   Price/Book(x)1.381.380.650.431.11
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)3.101.410.730.491.39
   EV/Core EBITDA(x)165.566.443.192.386.09
   EV/EBIT(x)-27.458.444.143.578.57
   EV/CE(x)0.880.880.470.250.72
   M Cap / Sales2.441.270.620.581.61
Growth Ratio
   Net Sales Growth(%)-55.3115.3260.2316.0288.81
   Core EBITDA Growth(%)-96.1910.0177.125.3786.78
   EBIT Growth(%)-130.178.80104.81-1.1266.43
   PAT Growth(%)-267.45-7.71113.24-11.11103.32
   EPS Growth(%)-267.45-7.71113.24-11.1137.63
Financial Stability Ratios
   Total Debt/Equity(x)0.720.500.430.210.12
   Current Ratio(x)2.072.222.984.074.11
   Quick Ratio(x)1.781.902.753.803.83
   Interest Cover(x)-0.573.154.884.576.27
   Total Debt/Mcap(x)0.520.360.670.500.11

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.